DocGo granted Nasdaq extension on $1 bid rule
DocGo Inc. reports that Nasdaq has granted additional time to regain compliance with the exchange’s minimum bid price rule.
Rhea-AI Filing Summary
DocGo Inc. reports that Nasdaq has granted additional time to regain compliance with the exchange’s minimum bid price rule. The company now has until January 25, 2027 to meet the Nasdaq Listing Rule 5550(a)(2) requirement that its common stock close at or above $1.00 per share for at least 10 consecutive business days. If this condition is met before the deadline, Nasdaq staff will confirm that the company has returned to compliance.
DocGo states that it will monitor its share price and evaluate options to regain compliance, including a possible reverse stock split. At the June 16, 2026 annual meeting, stockholders approved an amendment authorizing a reverse split at a ratio between 1-for-5 and 1-for-10, to be implemented at the board’s discretion.
Positive
- None.
Negative
- Non-compliance with Nasdaq bid rule is disclosed, with a deadline of January 25, 2027 to restore a minimum $1.00 bid price for 10 consecutive business days.
8-K Event Classification
Key Figures
Key Terms
Nasdaq Listing Rule 5550(a)(2) regulatory
Minimum Bid Requirement regulatory
reverse stock split financial
continued listing rule regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did DocGo Inc. (DCGO) announce regarding its Nasdaq listing?
What is the new deadline for DCGO to regain Nasdaq bid-price compliance?
What is Nasdaq’s Minimum Bid Requirement affecting DocGo (DCGO)?
What options is DocGo (DCGO) considering to regain Nasdaq compliance?
Has DocGo (DCGO) already implemented a reverse stock split?
Why is DocGo (DCGO) filing under the Nasdaq continued listing rule item?
AI-generated analysis. How Rhea-AI works. Not financial advice.